CHC Healthcare Group (4164) Fair Value & Analysis
Healthcare · TW · Market cap 6.0B TWD
Fair value as of: Jun 24, 2026
Analysis
CHC Healthcare Group (4164) currently trades at 30.55 TWD, while our model-based Fair Value estimate is 20.98 TWD — implying the stock looks roughly 31.3% overvalued today. We read business quality at 91/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).
About the company
CHC Healthcare Group, together with its subsidiaries, trades in medical equipment, pharmaceutical products, and health food in Taiwan, China, and internationally. The company is also involved in the leasing, installing, servicing, and repairing of medical instruments for use in various specialties, such as radiation oncology, medical imaging, neurology, surgery, ophthalmology, robot rehabilitation, dentistry, and smart health care. In addition, it engages in the irradiation business; sale of daily necessities, beauty products, and health supplements; elderly residence, long-term care, and senior services; leasing of veterinary medical instruments; department setup, business management consultation, and educational training and staff development for healthcare personnel; technical support and maintenance; radiation sterilization business; and online and physical store pharmacy chain activities. The company was formerly known as Cheng Yeh Holdings Co., Ltd. and changed its name to CHC…
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is CHC Healthcare Group (4164) undervalued?
What is the fair value of 4164?
What is the quality score of 4164?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.